Naples Money Management »

Crispr Therapeutics shares owned by Naples Money Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Naples Money Management from 13F filings

Historical chart of Naples Money Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Naples Money Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Naples Money Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.9k 30 62.60

More positions owned by Naples Money Management

Spdr S&p 500 Etf Trust Etf (SPY)
Microsoft Corp Stock (MSFT)
Stryker Corporation Stock (SYK)
Nvidia Corporation Stock (NVDA)
Teradyne Stock (TER)
Capital One Finl Corp Stock (COF)
Amazon Stock (AMZN)
Comfort Sys Usa Stock (FIX)
Best Buy Stock (BBY)
Marathon Pete Corp Stock (MPC)
Apple Stock (AAPL)
Progressive Corp Stock (PGR)
Tractor Supply Stock (TSCO)
Sysco Corp Stock (SYY)
Walmart Stock (WMT)

View all positions for Naples Money Management

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
Vanguard Group
NEA Management Company
Susquehanna International
Caption Management
Dimensional Fund Advisors
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Voloridge Investment Management
Ikarian Capital

View all funds holding Crispr Therapeutics